Perdomo-Lara SJ, Buenahora MR, Álvarez E, González-Martínez F, Rebolledo M, Aristizabal FA, et al. Human papilloma virus genotypes in dysplasia and epithelial hyperplasia of oral cavity using the luminex xmap technology. A multicenter study. Med Oral Patol Oral Cir Bucal. 2020 Jan 1;25 (1):e61-70.


1. Jemal A, Simard EP, Dorell C, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105:175-201.
PMid:23297039 PMCid:PMC3565628


2. Grulich AE, JIN F, Conway EL, Stein AN, Hocking J. Cancers attributable to human papillomavirus infection. Sex Health. 2010;7:244-52.


3. Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers - United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2012;61:258-61.


4. Jiang S, Dong Y. Human papillomavirus and oral squamous cell carcinoma: A review of HPV-positive oral squamous cell carcinoma and possible strategies for future. Curr Probl Cancer. 2017;41:323-27.


5. de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141:664-70.
PMid:28369882 PMCid:PMC5520228


6. Hübbers CU, Akgül B. HPV and cancer of the oral cavity. Virulence. 2015;6:244-8.
PMid:25654476 PMCid:PMC4601238


7. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199:1263-9.
PMid:19320589 PMCid:PMC4703086


8. Cook RL, Thompson EL, Kelso NE, et al. Sexual behaviors and other risk factors for oral human papillomavirus infections in young women. Sex Transm Dis. 2014;41:486-92.
PMid:25013976 PMCid:PMC5528151


9. Antonsson A, Cornford M, Perry S, Davis M, Dunne MP, Whiteman DC. Prevalence and risk factors for oral HPV infection in young Australians. PLoS One. 2014;9:e91761.
PMid:24637512 PMCid:PMC3956721


10. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006; 110:525-41.


11. Campisi G, Panzarella V, Giuliani M, Lajolo C, Di Fede O, Falaschini S, et al. Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review). Int J Oncol. 2007;30:813-23.


12. Cheng S, Schmidt-Grimminger DC, Murant T, Broker TR, Chow LT. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 1995;9:2335-49.


13. Izumo T. Oral premalignant lesions: from the pathological viewpoint. Int J Clin Oncol. 2011;16:15-26.


14. Sarode SC, Sarode GS, Karmarkar S, Tupkari JV. A new classification for potentially malignant disorders of the oral cavity. Oral Oncol. 2011;47:920-1.


15. Ramya AS, Majumdar S, Babu TM, Uppala D, Srinivas B, Rao AK. Expression of Human Papillomavirus DNA and p53 Polymorphisms through Polymerase Chain Reaction in Normal Mucosa and Oral Leukoplakia Individuals with Deleterious Oral Habits. Int J Appl Basic Med Res. 2017;7:134-8.
PMid:28584747 PMCid:PMC5441263


16. Ma J, Zhang J, Zhang Y, Lv T, Liu J. The Magnitude of the Association between Human Papillomavirus and Oral Lichen Planus: A Meta-Analysis. PLoS One. 2016;11:e0161339.
PMid:27571417 PMCid:PMC5003373


17. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401:70-9.
PMid:20206957 PMCid:PMC3400342


18. Szentirmay Z, Polus K, Tamas L, et al. Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations. Cancer Metastasis Rev. 2005; 24:19-34.


19. Jayaprakash V, Reid M, Hatton E, et al. Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010. Oral Oncol. 2011;47:1048-54.
PMid:21816661 PMCid:PMC3640331


20. Syrjänen S, Lodi G, von Bültzingslöwen I, Aliko A, Arduino P, Campisi G, et al. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis. 2011; 17 Suppl 1:58-72.


21. Hormia M, Willberg J, Ruokonen H, Syrjänen S. Marginal periodontium as a potential reservoir of human papillomavirus in oral mucosa. J Periodontol. 2005;76:58-63.


22. Jimenez C, Correnti M, Salma N, Cavazza ME, Perrone M. Detection of human papillomavirus DNA in benign oral squamous epithelial lesions in Venezuela. J Oral Pathol Med. 2001;30:385-88.


23. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of Papillomaviruses. Virology. 2004;324:17-27.


24. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401:70-9.
PMid:20206957 PMCid:PMC3400342


25. Zubach V, Smart G, Ratnam S, Severini A. Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types. J Clin Microbiol. 2012;50:460-4.
PMid:22116162 PMCid:PMC3264170


26. Álvarez GJ, Álvarez E, Jiménez R, Mosquera Y, Gaviria AM, Garcés A, et al. Reverse smokers's and changes in oral mucosa. Department of Sucre, Colombia. Med Oral Patol Oral Cir Bucal. 2008;13:E1-8.


27. Huang CG, Lee LA, Liao CT, Yen TC, Yang SL, Liu YC, et al. Molecular and serologic markers of HPV 16 infection are associated with local recurrence in patients with oral cavity squamous cell carcinoma. Oncotarget. 2017;8:34820-35.
PMid:28422732 PMCid:PMC5471014


28. Spector ME, Sacco AG, Bellile E, et al. E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma. Clin Cancer Res. 2017;23:2723-9.
PMid:27872102 PMCid:PMC5438906


29. Gomez-Armayones S, Chimenos-Küstner E, Marí A, Tous S, Penin R, Clavero O, et al. Human papillomavirus in premalignant oral lesions: No evidence of association in a Spanish cohort. PLoS One. 2019;14:e0210070.
PMid:30650110 PMCid:PMC6335078


30. Nankivell P, Williams H, Webster K, Pearson D, High A, MacLennan K, Senguven B, McConkey C, Rabbitts P, Mehanna H. Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia. J Oral Pathol Med. 2014;43:245-9.


31. Castellsagué X, Alemany L, Quer M, Halec G, Quirós B, Tous S, et al. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. J Natl Cancer Inst. 2016;108:djv403.


32. Chen X1, Zhao Y2. Human papillomavirus infection in oral potentially malignant disorders and cancer. Arch Oral Biol. 2017;83:334-9.


33.Tam S, Fu S, Xu L, Krause KJ, et al. The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis. Oral Oncol. 2018;82:91-9.


34. Mohammed KA, Subramaniam DS, Geneus CJ, Henderson ER, Dean CA, Subramaniam DP, Burroughs TE. Rural-urban differences in human papillomavirus knowledge and awareness among US adults. Prev Med. 2018;109:39-43.


35. Bui TC, Tran LT, Thai TN, Shete SS, Vidrine DJ, Sturgis EM. Prevalence of and Risk Factors for Oral Human Papillomavirus Infection with Multiple Genotypes in the United States. Sex Transm Dis. 2017;44:166-72.


36. Akhondnezhad M, Haghshenas MR, Ghasemi M, Mousavi T. The prevalence and genotyping of human papillomavirus in patients with oral tumors in health centers and clinics of Mazandaran in Iran. Virusdisease. 2018;29:297-302.
PMid:30159363 PMCid:PMC6111957


37. Anantharaman D, Abedi-Ardekani B, Beachler DC, Gheit T, Olshan AF, Wisniewski K, et al,. Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer. Int J Cancer. 2017;140:1968-75.


38. Gomez-Armayones S, Chimenos-Küstner E, Marí A, Tous S, Penin R, Clavero O et al. Human papillomavirus in premalignant oral lesions: No evidence of association in a Spanishcohort. PLoS One. 2019;14:e0210070.
PMid:30650110 PMCid:PMC6335078